Transcripta Bio

Palo Alto, United States · $34.0M raised

Headquarters
Palo Alto
Business Model
B2B
Total Funding
$34.0M
Last Round
$24.0M Series AJul 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Transcripta Bio is an AI-powered drug discovery company based in Palo Alto, California, developing small molecule treatments for neurological and neuromuscular diseases using whole-transcriptome data. The company's four-program drug discovery platform targets disease-relevant pathways, and it closed a $24 million Series A funding round in 2026, with backing that included Mayo Clinic Ventures, to advance its pipeline of novel therapeutics.

Summary

Transcripta Bio is an Artificial Intelligence company based in Palo Alto, United States. It has raised $34.0M in total across 2 rounds, most recently a $24.0M Series A round in Jul 2026. Investors include Jazz Venture Partners and BlueYard Capital.

Funding History

Series ASeries AJul 2026
$24.0M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Transcripta Bio on Indexed.vc
<a href="https://indexed.vc/companies/transcripta-bio"><img src="https://indexed.vc/api/badge/company/transcripta-bio" alt="Transcripta Bio on Indexed.vc" width="260" height="76" /></a>